Comparison results
Results: Differences Similar | ✘C96.2 | ✘Hyphema | |||||||
Related research | Analogs | Analogs | |||||||
| |||||||||
Distinctive symptoms | |||||||||
Register, to see more distinctive signs of diseases and studies | 47% | — | |||||||
Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||
feeling of fullness | 26% | — | |||||||
rupture of the eyeball | — | 77% | |||||||
chronic myeloid leukemia | 22% | — | |||||||
hemorrhage in the eye | — | 68% | |||||||
myelofibrosis | 22% | — | |||||||
shroud | — | 61% | |||||||
myeloid metaplasia | 20% | — | |||||||
sickle cell anemia | — | 60% | |||||||
hemorrhagic syndrome | 17% | — | |||||||
has a swelling of the eye | — | 59% | |||||||
multiple organ failure | 16% | — | |||||||
glaucoma | — | 59% | |||||||
aggressive | 13% | — | |||||||
photophobia | — | 58% | |||||||
control issues | 12% | — | |||||||
hemoglobinopathies | — | 58% | |||||||
cataract operated | — | 56% | |||||||
weak hazy vision | — | 56% | |||||||
thrombosis of the central retinal vein | — | 55% | |||||||
s eyes cloudy | — | 53% | |||||||
injury | — | 53% | |||||||
pain in the eyes | — | 51% | |||||||
spasm of accommodation | — | 51% | |||||||
eye injury | — | 50% | |||||||
vascular damage | — | 48% | |||||||
rubeosis of iris | — | 47% | |||||||
penetrating eye injury | — | 46% | |||||||
bruises on the body | — | 45% | |||||||
consequences of injuries | — | 45% | |||||||
hemorrhagic purpura | — | 45% | |||||||
foreign bodies of the eye | — | 45% | |||||||
subconjunctival hemorrhage | — | 44% | |||||||
choroid melanoma | — | 44% | |||||||
melanoma of the eye | — | 44% | |||||||
eye surgery | — | 44% | |||||||
inflammation of the eyes | — | 44% | |||||||
blurred vision | — | 43% | |||||||
hemophilia | — | 42% | |||||||
secondary cataract | — | 42% | |||||||
occlusion of the central retinal vein | — | 41% | |||||||
glaucoma and cataracts | — | 41% | |||||||
visual impairment | — | 40% | |||||||
deterioration from apples | — | 40% | |||||||
flies in front of the eyes | — | 40% | |||||||
acute leukemia | — | 39% | |||||||
vascular tumor | — | 39% | |||||||
chronic inflammation of the eyes | — | 39% | |||||||
fisher-evans syndrome | — | 38% | |||||||
diabetes mellitus | — | 38% | |||||||
secondary glaucoma | — | 38% | |||||||
with anemia | — | 38% | |||||||
headaches | — | 37% | |||||||
melanoma | — | 37% | |||||||
the consequences of injury | — | 37% | |||||||
headache behind the eyes | — | 36% | |||||||
bleeding | — | 36% | |||||||
blood diseases | 16% | 52% | |||||||
retinitis | — | 36% | |||||||
wounds | — | 36% | |||||||
autoimmune thrombocytopenia | — | 36% | |||||||
pain after injury | — | 36% | |||||||
need for protection | — | 35% | |||||||
consequences of operation | — | 35% | |||||||
headache with dizziness | — | 34% | |||||||
bruise | — | 34% | |||||||
primary immunodeficiency | — | 34% | |||||||
skin overgrowth | — | 33% | |||||||
bruise | — | 33% | |||||||
cataract | — | 32% | |||||||
arterial bleeding | — | 32% | |||||||
hemorrhages on the skin | — | 32% | |||||||
cancer in the anamnesis | — | 32% | |||||||
better from pressure | — | 32% | |||||||
vasculitis | — | 32% | |||||||
chronic anemia | — | 31% | |||||||
venous thrombosis | — | 31% | |||||||
venous congestion | — | 31% | |||||||
blindness | — | 30% | |||||||
motor activity | — | 30% | |||||||
oncology in the anamnesis | — | 30% | |||||||
a history of trauma | — | 30% | |||||||
fistula | — | 30% | |||||||
thrombocytopenia | — | 29% | |||||||
traumatic illness | — | 29% | |||||||
bleeding | — | 29% | |||||||
metastases | — | 29% | |||||||
consequences of taking medications | 11% | 40% | |||||||
dizziness | — | 28% | |||||||
hemorrhagic diathesis | — | 28% | |||||||
immunodeficiency | — | 27% | |||||||
spasm | — | 27% | |||||||
thrombosis | — | 26% | |||||||
hypertension | — | 25% | |||||||
angiopathy | — | 25% | |||||||
skin problems | — | 24% | |||||||
chronic leukemia | 21% | 44% | |||||||
chronic lymphocytic | 18% | 38% | |||||||
oncology | 22% | 41% | |||||||
cancer | 24% | 43% | |||||||
patient's condition | 11% | 23% | |||||||
leukemia | 27% | 33% | |||||||
lymphocytic | 27% | 33% |
Instructions
Video
|